<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25013818</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2014</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Increased frequency of circulating follicular helper T cells in children with hand, foot, and mouth disease caused by enterovirus 71 infection.</ArticleTitle><Pagination><StartPage>651872</StartPage><MedlinePgn>651872</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">651872</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/651872</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD) in children. The role of T follicular helper (TFH) cells in EV71-infected children remains unclear in regulating humoral immunity. The frequency of circulating ICOS(high)/PD-1(high)CXCR5(+)CD4(+) TFH cells in the children with mild and severe EV71 infection and healthy controls (HC) was detected by flow cytometry, respectively. IL-21 and IL-6 mRNA expression and their serum levels, Bcl-6 mRNA expression, and specific neutralizing antibodies against EV71 (NAb-EV71) were measured. In the acute stage of patients with EV71 infection, increased frequencies of circulating TFH cells with ICOS(high) and PD-1(high) expression in the mild and severe patients were observed, and the positive correlations among the frequencies of circulating TFH cells and the serum levels of IL-21, IL-6, and NAb-EV71 titres were detected, respectively. Moreover, the expressions of IL-6 and IL-21 mRNA in PBMCs from patients were also significantly higher than those of HC. However, further analysis did not reveal any significant differences between mild and severe patients. These data indicate a role of TFH cells and associated cytokines in modulating the humoral response during the pathogenesis of EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xianzhi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Jianzhou</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Center of Community Health Service of Qingbo Street, Hangzhou 310002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Xianfei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Zhimei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dejian</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Zhaoxia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Guoliang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Shufa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology and Center of Infection and Immunology, The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054380">Receptors, CXCR5</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000954" MajorTopicYN="N">Antigens, Surface</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054380" MajorTopicYN="N">Receptors, CXCR5</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006377" MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25013818</ArticleId><ArticleId IdType="pmc">PMC4071862</ArticleId><ArticleId IdType="doi">10.1155/2014/651872</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasri D, Bouslama L, Pillet S, Bourlet T, Aouni M, Pozzetto B. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Review of Molecular Diagnostics. 2007;7(4):419&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-C, Chang H-L, Yan T-R, Cheng Y-T, Chen K-T. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. The American Journal of Tropical Medicine and Hygiene. 2007;77(1):188&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Deng C, Wan J, Zhu L, Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virology Journal. 2011;8, article 306</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3142239</ArticleId><ArticleId IdType="pubmed">21679417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Li N, Yu X, et al. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Archives of Virology. 2012;157(1):37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">21984267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, El Khatib NF, Tu S, et al. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. Journal of Clinical Virology. 2012;53(4):285&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W-C, Huang L-M, Kao C-L, et al. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. Journal of Microbiology, Immunology and Infection. 2012;45(2):96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L-Y, Hsiung CA, Lu C-Y, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatric Research. 2006;60(4):466&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7086547</ArticleId><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Lei H-Y, Huang K-J, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. Journal of Infectious Diseases. 2003;188(4):564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelman FD, Holmes J, Katona IM, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annual Review of Immunology. 1990;8:303&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">1693082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma CS, Suryani S, Avery DT, et al. Early commitment of nave human CD4+ T cells to the T follicular helper (FH) cell lineage is induced by IL-12. Immunology and Cell Biology. 2009;87(8):590&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">19721453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology. 1989;7:145&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">2523712</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology. 2005;6(11):1123&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">16200070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Jie M, Liu Y, et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism. 2012;97(3):943&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">22188745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke MA, Eto D, Locci M, et al. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. Journal of Immunology. 2012;188(8):3734&#x2013;3744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324673</ArticleId><ArticleId IdType="pubmed">22427637</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. The Journal of Experimental Medicine. 2000;192(11):1545&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193094</ArticleId><ArticleId IdType="pubmed">11104797</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. Journal of Experimental Medicine. 2000;192(11):1553&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193097</ArticleId><ArticleId IdType="pubmed">11104798</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold CN, Campbell DJ, Lipp M, Butcher EC. The germinal center response is impaired in the absence of T cell-expressed CXCR5. European Journal of Immunology. 2007;37(1):100&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17171760</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity. 2009;30(3):324&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2731675</ArticleId><ArticleId IdType="pubmed">19303387</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes NM, Allen CDC, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1High germinal center-associated subpopulation. Journal of Immunology. 2007;179(8):5099&#x2013;5108.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911595</ArticleId></ArticleIdList></Reference><Reference><Citation>Spolski R, Leonard WJ. IL-21 and T follicular helper cells. International Immunology. 2009;22(1):7&#x2013;12.dxp112</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795365</ArticleId><ArticleId IdType="pubmed">19933709</ArticleId></ArticleIdList></Reference><Reference><Citation>Eto D, Lao C, DiToro D, et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE. 2011;6(3)e17739</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056724</ArticleId><ArticleId IdType="pubmed">21423809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Juedes AE, Temann U-A, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 2001;409(6816):97&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343121</ArticleId></ArticleIdList></Reference><Reference><Citation>Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends in Immunology. 2006;27(4):195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">16500147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf I, Kageyama R, Monticelli L, et al. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150) Journal of Immunology. 2010;185(1):190&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2913439</ArticleId><ArticleId IdType="pubmed">20525889</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D, Vinuesa CG. The elusive identity of T follicular helper cells. Trends in Immunology. 2010;31(10):377&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">20810318</ArticleId></ArticleIdList></Reference><Reference><Citation>Linterman MA, Rigby RJ, Wong R, et al. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity. 2009;30(2):228&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">19217324</ArticleId></ArticleIdList></Reference><Reference><Citation>Locci M, Havenar-Daughton C, Landais E, et al. Human circulating PD-1+1CXCR3&#x2212;CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity. 2013;39(4):758&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3996844</ArticleId><ArticleId IdType="pubmed">24035365</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Lu L, Hua C, et al. High frequency of CD4+CXCR5+ TFH cells in patients with immune-active chronic hepatitis B. PLoS ONE. 2011;6(7)e21698</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131291</ArticleId><ArticleId IdType="pubmed">21750724</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovas C, Yamamoto T, Gerner MY, et al. CD4 T follicular helper cell dynamics during SIV infection. Journal of Clinical Investigation. 2012;122(9):3281&#x2013;3294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428091</ArticleId><ArticleId IdType="pubmed">22922258</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson N, Gatenby PA, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis and Rheumatism. 2010;62(1):234&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">20039395</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Cai C, Feng J, et al. Peripheral T lymphocyte subset imbalances in children with enterovirus 71-induced hand, foot and mouth disease. Virus Research. 2014;180:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24316007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Tong J, Liu H, et al. Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71. Journal of Medical Virology. 2012;84(5):763&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">22431024</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Jiao Y, Qiu Z, Li Q, Li T. Significant elevation of B cells at the acute stage in enterovirus 71-infected children with central nervous system involvement. Scandinavian Journal of Infectious Diseases. 2010;42(11-12):931&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">20950217</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Zhou X, Yang E, et al. Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys. Journal of Clinical Immunology. 2012;32(5):1048&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">22585051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-W, Chang K-C, Kao C-M, Chang S-P, Tung Y-Y, Chen S-H. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. Journal of Virology. 2009;83(13):6477&#x2013;6483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation> National notifiable diseases announced by National Health and Family Planning Commission of the People&#x2019;s Republic of China,  http://www.nhfpc.gov.cn/zhuzhan/yqxx/lists.shtml.</Citation></Reference><Reference><Citation>Morita R, Schmitt N, Bentebibel S-E, et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046815</ArticleId><ArticleId IdType="pubmed">21215658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>